Therapeutic insights into he treatment of stroke, multiple sclerosis, and Alzheimer’s disease: Argonaute-2 promotes neuroprotection via up regulation of its target gene, 24/September/2014, 6.31 am

MiRNA-based therapy for Psoriasis: Lin-28 inhibits psoriasiform skin inflammation via up regulation of its target gene, 24/September/2014, 06.25 am
September 24, 2014
Interlekin-mediated tumor suppression: IL-1β suppresses the expression of a negative regulator of p53 HDM2 via up regulation of its target gene, 24/September/2014, 06.48 am
September 24, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Therapeutic insights into he treatment of stroke, multiple sclerosis, and Alzheimer’s disease: Argonaute-2 promotes neuroprotection via up regulation of its target gene, 24/September/2014, 6.31 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that Argonaute-2by up regulating the expression of its target gene, it  may promote survival of Neurons.  Thus, pharmacological formulations encompassing Argonaute-2 activator” may be used to treat: (1) hypoxic-ischemic brain injury ; (2) Stroke; (3) Multiple sclerosis; and (4) Alzhemer’s disease.

* Research cooperation

Comments are closed.